Connect your AI

Tandem Diabetes Care TNDM Gross Profit

Gross Profit at other companies

InsuletPODD

$529M+29.3%

MedtronicMDT

$6.41B+10.9%

AdaptHealthAHCO

$111.5M-7.4%

MannkindMNKD

$82.66M+10.8%

AbbottABT

$6.27B+6.5%

OmnicellOMCL

$140.36M+26.5%

Other financials

Income statement

Revenue$247.2M+5.5%

Operating income-$17.4M+85.6%

Net income-$20.4M+84.4%

EPS (diluted)-$0.30+84.8%

Balance sheet

Cash & equivalents$179.3M+235%

Total debt$734.7M+49.0%

Total equity$132.4M-14.7%

Total assets$1.2B+25.1%

Cash flow

Operating cash flow$11.1M+160%

CapEx$6.3M+111%

Free cash flow$4.8M+123%

Valuation

Market cap$1.03B-23.6%

Enterprise value$1.58B-11.3%

P/S1×-0.4×

Profitability

Gross margin54.9%+2.7pp

Operating margin-8.2%-2.9pp

Net margin-9.2%-3.1pp

FCF margin-0.8%-0.4pp

Returns & leverage

Return on equity-65.7%-14.7pp

Debt / equity5.5×+2.4×

Current ratio3.6×+1.3×

Where this comes from

Calculated from Tandem Diabetes Care’s reported figures.

$247.2Mtotal revenue−$110.4Mtotal cost of revenue=$136.79M

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Tandem Diabetes Care's gross profit?: Tandem Diabetes Care (TNDM) reported gross profit of $136.79M in Q1 2026.
How has Tandem Diabetes Care's gross profit changed year-over-year?: Tandem Diabetes Care's gross profit increased by 15.5% year-over-year, from $118.41M to $136.79M.
What is the long-term trend for Tandem Diabetes Care's gross profit?: Over 4 years (2021 to 2025), Tandem Diabetes Care's gross profit has grown at a 9.8% compound annual growth rate (CAGR), from $376.22M to $546.01M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.